Journal
IMMUNOLOGICAL REVIEWS
Volume 281, Issue 1, Pages 124-137Publisher
WILEY
DOI: 10.1111/imr.12615
Keywords
autoinflammatory disorders; cancer; cell death; IL-1
Categories
Funding
- US National Institutes of Health [AI101935, AI124346, AR056296, CA163507]
- ALSAC
- NATIONAL CANCER INSTITUTE [R01CA163507] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI101935, R01AI124346] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056296] Funding Source: NIH RePORTER
Ask authors/readers for more resources
The interleukin (IL)-1 family of cytokines is currently comprised of 11 members that have pleiotropic functions in inflammation and cancer. IL-1 and IL-1 were the first members of the IL-1 family to be described, and both signal via the same receptor, IL-1R. Over the last decade, much progress has been made in our understanding of biogenesis of IL-1 and its functions in human diseases. Studies from our laboratory and others have highlighted the critical role of nod-like receptors (NLRs) and multi-protein complexes known as inflammasomes in the regulation of IL-1 maturation. Recent studies have increased our appreciation of the role played by IL-1 in inflammatory diseases and cancer. However, the mechanisms that regulate the production of IL-1 and its bioavailability are relatively understudied. In this review, we summarize the distinctive roles played by IL-1 in inflammatory diseases and cancer. We also discuss our current knowledge about the mechanisms that control IL-1 biogenesis and activity, and the major unanswered questions in its biology.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available